Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE1
Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE2
T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Cardiac Safe Transplants for Systemic Sclerosis
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
QUILT-3.080: NANT Pancreatic Cancer Vaccine
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
CD19-Specific T Cells Post AlloSCT
- Status
- TERMINATED
- Phase
- PHASE1
Liver Transplantation With Tregs at MGH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3